tiprankstipranks
Nirvana Life Sciences Inc (TSE:NIRV)
CNQX:NIRV
Canadian Market

Nirvana Life Sciences Inc (NIRV) Stock Price & Analysis

5 Followers

NIRV Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.01 - C$0.12
Previous CloseC$0.02
Volume0.00
Average Volume (3M)37.52K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)C$3.14K
Total Debt (Recent Filing)C$23.62K
Price to Earnings (P/E)
Beta3.12
Aug 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding48,233,010
10 Day Avg. Volume2,564
30 Day Avg. Volume37,518
Standard Deviation0.44
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-0.49
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-14.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

31.07%0.00%0.00%68.93%
31.07% Insiders
0.00% Other Institutional Investors
68.93% Public Companies and
Individual Investors

NIRV FAQ

What was Nirvana Life Sciences Inc’s price range in the past 12 months?
Nirvana Life Sciences Inc lowest stock price was C$0.01 and its highest was C$0.12 in the past 12 months.
    What is Nirvana Life Sciences Inc’s market cap?
    Currently, no data Available
    When is Nirvana Life Sciences Inc’s upcoming earnings report date?
    Nirvana Life Sciences Inc’s upcoming earnings report date is Aug 26, 2024 which is in 35 days.
      How were Nirvana Life Sciences Inc’s earnings last quarter?
      Currently, no data Available
      Is Nirvana Life Sciences Inc overvalued?
      According to Wall Street analysts Nirvana Life Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Nirvana Life Sciences Inc pay dividends?
        Nirvana Life Sciences Inc does not currently pay dividends.
        What is Nirvana Life Sciences Inc’s EPS estimate?
        Nirvana Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Nirvana Life Sciences Inc have?
        Nirvana Life Sciences Inc has 39,893,265 shares outstanding.
          What happened to Nirvana Life Sciences Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Nirvana Life Sciences Inc?
          Currently, no hedge funds are holding shares in TSE:NIRV
          ---

          Nirvana Life Sciences Inc Stock Smart Score

          Company Description

          Nirvana Life Sciences Inc

          Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Reliq Health Technologies
          BriaCell Therapeutics
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis